Veronica Schimp

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Maspin expression and localization impact on angiogenesis and prognosis in ovarian cancer

L. A. Solomon, Adnan Munkarah, Veronica Schimp et al. · Gynecologic Oncology · 2006 · 71 citations

Medicine, Cancer Biology, Oncology +16

Vacuum-assisted closure in the treatment of gynecologic oncology wound failures

Veronica Schimp, Cynthia A Worley, Sandi Brunello et al. · Gynecologic Oncology · 2004 · 60 citations

Medicine, Oncology, Surgery +14

Expression of cyclooxygenase-2 in advanced stage ovarian serous carcinoma: Correlation with tumor cell proliferation, apoptosis, angiogenesis, and survival

Rouba Ali‐Fehmi, Robert Morris, Mingxin Che et al. · American Journal of Obstetrics and Gynecology · 2005 · 55 citations

Medicine, Cell Biology, Oncology +13

Increased expression of hypoxia-inducible factor 1α in type I and type II endometrial carcinomas

Vaishali Pansare, Adnan Munkarah, Veronica Schimp et al. · Modern Pathology · 2006 · 54 citations · Full text

Medicine, Oncology, Pathology +12